Richter, M. H.; Maringanti, R.; Adrian Segarra, J. M.; Lautze, H.; Schoenburg, M.; Skwara, W.; Hein, S.; van Linden, A.; Kubin, T.; Braun, T.et al.; Kostin, S.; Walther, T.: The Interleukin 4 Receptor-alpha Potentiates the Effect of Oncostatin M Receptor on the Release of FGF23 by Cardiomyocytes. JOURNAL OF HEART AND LUNG TRANSPLANTATION 35 (4), p. S180 - S180 (2016)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).